-ADVERTISEMENT-

Tag: dsm-firmenich

(Image: dsm-firmenich) dsm-firmenich has announced a victory before the US Patent and Trademark Office (USPTO) in defending a patent from an invalidation action recently levied by Mara Renewables Corporation. The USPTO’s Patent Trial and Appeal Board (PTAB) rejected Mara Renewables’ request for inter partes review (IPR) and cancellation of US Patent...
The two HMOs that received approval in China include GlyCare 2’-fucosyllactose (2’-FL) and GlyCare lacto-N dsm-firmenich has announced that two of its human milk oligosaccharide (HMO) ingredients have been approved as fortifiers for infant nutrition in China. This approval is a significant milestone as it will create new opportunities for...
HMOs are emerging ingredients and important components of human breast milk that play fundamental roles in infant nutrition and health by supporting gut health, immune function and potentially cognitive development dsm-firmenich has confirmed plans to expand its human milk oligosaccharide (HMO) portfolio in China with two new ingredient submissions to...